Atlas Trials

Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

Clinical trial NCT00323219 · COMPLETED

Trial details

NCT number
NCT00323219
Sponsor
University of British Columbia
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cellulitis
Start date
2004-01-01
Primary completion
2012-12-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.